Redmond Asset Management LLC lessened its stake in shares of HCA Healthcare Inc (NYSE:HCA) by 17.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 21,761 shares of the company’s stock after selling 4,487 shares during the period. HCA Healthcare accounts for 1.2% of Redmond Asset Management LLC’s portfolio, making the stock its 25th largest holding. Redmond Asset Management LLC’s holdings in HCA Healthcare were worth $3,027,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds also recently made changes to their positions in the business. FMR LLC boosted its position in shares of HCA Healthcare by 98.7% in the third quarter. FMR LLC now owns 10,907,407 shares of the company’s stock valued at $1,517,438,000 after acquiring an additional 5,419,134 shares during the period. LSV Asset Management boosted its position in shares of HCA Healthcare by 0.3% in the third quarter. LSV Asset Management now owns 5,474,392 shares of the company’s stock valued at $761,597,000 after acquiring an additional 15,004 shares during the period. Northern Trust Corp boosted its position in shares of HCA Healthcare by 4.2% in the second quarter. Northern Trust Corp now owns 3,460,267 shares of the company’s stock valued at $355,023,000 after acquiring an additional 138,135 shares during the period. Bank of New York Mellon Corp boosted its position in shares of HCA Healthcare by 15.6% in the third quarter. Bank of New York Mellon Corp now owns 2,406,809 shares of the company’s stock valued at $334,834,000 after acquiring an additional 324,724 shares during the period. Finally, Massachusetts Financial Services Co. MA boosted its position in shares of HCA Healthcare by 98.3% in the third quarter. Massachusetts Financial Services Co. MA now owns 1,767,715 shares of the company’s stock valued at $245,925,000 after acquiring an additional 876,226 shares during the period. Institutional investors own 69.94% of the company’s stock.
Several equities research analysts have recently weighed in on the company. SunTrust Banks increased their price objective on HCA Healthcare to $150.00 and gave the company a “positive” rating in a research report on Tuesday, September 4th. Leerink Swann increased their price objective on HCA Healthcare from $140.00 to $150.00 and gave the company an “outperform” rating in a research report on Tuesday, September 4th. Argus increased their price objective on HCA Healthcare to $150.00 and gave the company a “buy” rating in a research report on Friday, September 7th. Credit Suisse Group increased their price objective on HCA Healthcare from $156.00 to $165.00 and gave the company an “outperform” rating in a research report on Thursday, November 1st. Finally, Zacks Investment Research raised HCA Healthcare from a “hold” rating to a “buy” rating and set a $151.00 price objective for the company in a research report on Monday, November 26th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. HCA Healthcare presently has an average rating of “Buy” and a consensus target price of $144.15.
Shares of HCA stock opened at $143.99 on Monday. The firm has a market capitalization of $49.56 billion, a P/E ratio of 21.85, a PEG ratio of 1.26 and a beta of 0.51. HCA Healthcare Inc has a one year low of $77.76 and a one year high of $145.74.
HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, October 30th. The company reported $2.16 EPS for the quarter, topping the consensus estimate of $1.93 by $0.23. The firm had revenue of $11.45 billion during the quarter, compared to analysts’ expectations of $11.29 billion. HCA Healthcare had a negative return on equity of 73.71% and a net margin of 6.82%. HCA Healthcare’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period last year, the business earned $1.13 earnings per share. On average, analysts predict that HCA Healthcare Inc will post 9.34 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 28th. Shareholders of record on Monday, December 3rd will be issued a dividend of $0.35 per share. The ex-dividend date is Friday, November 30th. This represents a $1.40 dividend on an annualized basis and a dividend yield of 0.97%. HCA Healthcare’s payout ratio is presently 21.24%.
TRADEMARK VIOLATION WARNING: This piece was published by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be accessed at https://www.com-unik.info/2018/12/03/redmond-asset-management-llc-has-3-03-million-holdings-in-hca-healthcare-inc-hca.html.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Further Reading: How can you know how many shares are floating?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.